The latest immunotherapy news and developments
Boost for UNSW brain cancer and joint replacement research
A clinical trial of a new immunotherapy that will deliver a “toxin bomb” to brain…
Browsing: Immunotherapy
Aging immune system may explain age-related cancer risk increase
The key to cancer prevention may lie in the immune system rather than genetic mutations,…
30 year treatment drought breaks for most common form of bladder cancer
The Therapeutic Goods Administration has approved pembrolizumab (KEYTRUDA 200mg, every three weeks) as monotherapy for…
‘Immunomap’ suggests more is better when it comes to immune cell receptors and patients’ response to immunotherapy
Johns Hopkins scientists have used a form of artificial intelligence to create a map that…
Could viruses take cancer immunotherapy to the next level?
Immunotherapy, which helps the body’s immune system attack cancer, has revolutionised treatment for cancers such…
Deep sea creatures provide a guiding light in the quest to develop cancer therapies
A team of scientists at the Keck School of Medicine of USC is looking to…
Cancer immunotherapy may work better in patients with specific genes
Cancer cells arise when DNA is mutated, and these cells should be recognised as “foreign”…
SABCS 2017: Immunotherapy shows early promise for patients with trastuzumab-resistant breast cancer
A combination of pembrolizumab and trastuzumab, tested in patients with trastuzumab-resistant advanced HER2-positive breast cancer,…
New vaccine technique effectively fights breast cancer in mice
A new vaccine technique can fight a certain type of breast cancer in mice. So-called…
Molecular profiling of melanoma tumours explains differences in survival after T cell therapy
The more times metastasised melanoma has mutated and the patient’s immune system has been activated…